Organization | National Taiwan Sport University

National Taiwan Sport University Report issue

Academic/Hospital

Organization Overview

First Clinical Trial

2019

NCT04293666

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

Chi-Chang Huang | Chin Hsu | National Taiwan Sport University

Active Ingredients

Drugs in Other Trials (6)

caffeine (3 trials)

kefir (1 trial)

lactobacillus casei (1 trial)

lactobacillus plantarum (2 trials)

maltodextrin (2 trials)

verbena (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 8
# of Trial APIs: 6